In addition to the investment, WuXi NextCode is partnering with DNAnexus to offer cloud-based analysis infrastructure to customers in China.
GATC Biotech will sell and market Molecular Health's TreatmentMap next-generation sequencing-based tumor profiling platform around the world.
UC Davis will use molecular information from Foundation to drive targeted programs and will share outcomes data to incorporate into FoundationCORE.
AstraZeneca will use the Bina Genomic Management Solution to support genomic data analysis as part of its drug development in three therapeutic areas.
The partners will create a platform that can quickly process population-level genomic data sets by integrating Edico Genome's Dragen and Intel's Xeon processors.
In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.
Stanford University researchers are studying top athletes to uncover genes linked to performance.
The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.
This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.